TECH - Bio-Techne Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
202.87
+2.44 (+1.21%)
As of 2:54PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close200.43
Open200.92
Bid202.16 x 900
Ask202.39 x 800
Day's Range199.45 - 203.36
52 Week Range132.75 - 217.16
Volume103,815
Avg. Volume164,926
Market Cap7.687B
Beta (3Y Monthly)1.40
PE Ratio (TTM)82.13
EPS (TTM)2.47
Earnings DateOct 28, 2019 - Nov 1, 2019
Forward Dividend & Yield1.28 (0.65%)
Ex-Dividend Date2019-08-15
1y Target Est228.75
Trade prices are not sourced from all markets
  • PR Newswire

    Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility

    MINNEAPOLIS , Sept. 16, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media manufacturing ...

  • GuruFocus.com

    Bio-Techne Corp (TECH) Files 10-K for the Fiscal Year Ended on June 30, 2019

    Bio-Techne Corp (TECH) files its latest 10-K with SEC for the fiscal year ended on June 30, 2019. Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products. Continue reading...

  • Bio-Techne (NASDAQ:TECH) Shareholders Booked A 99% Gain In The Last Five Years
    Simply Wall St.

    Bio-Techne (NASDAQ:TECH) Shareholders Booked A 99% Gain In The Last Five Years

    Bio-Techne Corporation (NASDAQ:TECH) shareholders have seen the share price descend 11% over the month. But that...

  • 5 Tips for Making Money in Penny Stocks
    InvestorPlace

    5 Tips for Making Money in Penny Stocks

    [Editor's note: This story was previously published in April 2018. It has since been updated and republished.]First, let's get something straight. The definition of penny stocks is entirely subjective. What I think constitutes a risky penny stock, you might feel is a robust, thriving enterprise. Therefore, before I answer the question of whether you can make money in penny stocks, I'm going to explain what I believe is the best definition of a penny stock. From there, I'll tackle the five rules investors should follow to be successful in trading penny stocks.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe Definition: Merriam-Webster defines penny stock as "a usually unlisted highly speculative stock usually selling for a dollar or less." Hence, the penny-stock moniker. Others are more liberal in their interpretation of what constitutes a penny stock.The Successful Investor, an investment newsletter publisher I do some work for here in Canada, suggests the ceiling price can go as high as $5. * 7 Retail Stocks to Buy on the Dip Here's what the SEC has to say about penny stocks:"The term 'penny stock' generally refers to a security issued by a very small company that trades at less than $5 per share," states the SEC website. "Penny stocks generally are quoted over-the-counter, such as on the OTC Bulletin Board; penny stocks may, however, also trade on securities exchanges, including foreign securities exchanges."So, I've got reputable sources from both the U.S. and Canada who accurately define what penny stocks are, including the price at which they trade.At $5 or less, I do believe you can make money in stocks, but it helps if you follow these five simple rules.For every success story like Monster Beverage (NASDAQ:MNST), which traded below $5 as recently as 2006, there are hundreds of penny stock failures littered along the investment highway. * The Elite 8 Stocks to Buy for Massive Outperformance Treat penny stocks just as you would any other publicly traded investment, and your chances for success increase exponentially. Tip 1: Buy Companies With Strong Balance SheetsSource: Shutterstock Like any equity investment, it's important that you establish the financial strength of the company. When I look for stocks to invest in whether the share price is $5 or $500, I focus on companies with strong balance sheets. Although no debt is desirable when interest rates are rising, it's not very practical. This is especially true when it comes to penny stocks, many of which are still in the early stages of development. Here are two rules:1\. Only invest in companies whose long-term debt (LTD) is 50% of shareholder equity or less. If a company has $1 million in debt, its shareholder equity should be at least $2 million. 2\. Try to keep your penny-stock bets to those companies whose LTD is less than its market cap; the lower, the better. Tip 2: Buy Profitable CompaniesSource: (C)iStock.com/graphicnoi As with any equity investment, it's important that you limit your investments to profitable businesses. There are two schools of thought on this. On the one hand, investing in publicly-traded companies, whether they're penny stocks or not, provides you with greater liquidity than private investments. Therefore, the ability to exit quicker justifies the higher risk many in this arena are willing to accept to generate outsize future gains. On the other hand, private investments have longer holding periods built into them -- often 3-5 years or more -- which means investors aren't nearly as concerned about profitability as they are with growth. * 10 Marijuana Stocks That Could See 100% Gains, If Not More It really comes down to your ability to handle uncertainty. For me, I'm always looking for companies making money in the here and now. Anything less is called speculation, and while there's nothing wrong with this approach, it's not something novice investors ought to consider. Tip 3: Understand the BusinessSource: Shutterstock Like any equity investment, it's important that you understand the businesses you invest in. There's a saying that if you can't explain what a company's business does in a sentence or two, you probably shouldn't be investing.Imagine you're explaining the investment to your child who attends elementary school. It's easy to describe what Coca-Cola (NYSE:KO) does: it makes soda pop. It's not nearly as simple to describe what business Bio-Techne (NASDAQ:TECH) is in.At least it's not for me. Stick to what you know and understand. That's especially true with penny stocks with smaller market caps. Tip 4: Diversify Source: Simon Cunningham via FlickrLike any equity investment, it's important that you diversify your penny stocks. How many penny stocks should you own? That's the million-dollar question, no matter how big or small the investment. Some professional investors believe you've got to have a concentrated portfolio of your best ideas -- say 10 to 20 -- while others think you should spread your bets far wider over 100 stocks or more. It's a subjective answer for sure. * 10 Undervalued Stocks With Breakout Potential What I do know is that you want to be in at least three or four sectors of the economy that generally are healthy and growing.Since the risk/reward ratio of penny stocks can be significantly higher than that of large-cap stocks such as Coca-Cola, it's far more important to diversify your investments. Tip 5: Risk What You Can Afford to LoseSource: Shutterstock Like any equity investment, it's important that you understand there are no guarantees and that you're risking the money you can afford to lose.If your child's going off to university in a couple of years and the funds you've allocated for investing will pay his or her tuition, you might want to keep your funds parked in something more stable.As of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Tech Stocks That Transformed Their Business * 8 Genomic Testing Stocks That Can Ease the Sting of Theranos * 7 Weak Blue-Chip Stocks to Trim Immediately The post 5 Tips for Making Money in Penny Stocks appeared first on InvestorPlace.

  • PR Newswire

    Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice™ System

    MINNEAPOLIS , Aug. 20, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of the Maurice Empower ® Control Kit for the ProteinSimple™-branded Maurice platform. This ...

  • Bio-Techne To Present At The Baird 2019 Global Healthcare Conference
    PR Newswire

    Bio-Techne To Present At The Baird 2019 Global Healthcare Conference

    MINNEAPOLIS , Aug. 15, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth , President and Chief Executive Officer, will present at the Baird 2019 Global Healthcare ...

  • New Strong Sell Stocks for August 15th
    Zacks

    New Strong Sell Stocks for August 15th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

  • PR Newswire

    Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay

    MINNEAPOLIS and SOUTHPORT, N.C. , Aug. 13, 2019 /PRNewswire/ -- Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification ...

  • Thomson Reuters StreetEvents

    Edited Transcript of TECH earnings conference call or presentation 6-Aug-19 1:00pm GMT

    Q4 2019 Bio-Techne Corp Earnings Call

  • Bio-Techne Corp (TECH) Q4 2019 Earnings Call Transcript
    Motley Fool

    Bio-Techne Corp (TECH) Q4 2019 Earnings Call Transcript

    TECH earnings call for the period ending August 6, 2019.

  • Techne (TECH) Q4 Earnings and Revenues Lag Estimates
    Zacks

    Techne (TECH) Q4 Earnings and Revenues Lag Estimates

    Techne (TECH) delivered earnings and revenue surprises of -4.58% and -3.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • PR Newswire

    Bio-Techne Declares Dividend

    MINNEAPOLIS , Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2019 ...

  • PR Newswire

    Bio-Techne Releases Fourth Quarter Fiscal 2019 Results

    MINNEAPOLIS , Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2019 . Fourth Quarter FY2019 Snapshot Fourth quarter ...

  • Bio-Techne Corporation (NASDAQ:TECH): Earnings To Drop Next Year
    Simply Wall St.

    Bio-Techne Corporation (NASDAQ:TECH): Earnings To Drop Next Year

    Looking at Bio-Techne Corporation's (NASDAQ:TECH) earnings update in March 2019, analyst consensus outlook seem...

  • Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?
    Zacks

    Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?

    Within the Health Care Benefits segment, CVS Health (CVS) expects the government programs to go from strength to strength on the back of Medicare growth and major Medicaid wins.

  • What's in Store for Cardinal Health (CAH) in Q4 Earnings?
    Zacks

    What's in Store for Cardinal Health (CAH) in Q4 Earnings?

    Better-than-expected performance at Pharmaceutical and Medical segments are likely to aid Cardinal Health's (CAH) in Q4 earnings.

  • Henry Schein (HSIC) to Post Q2 Earnings: A Beat in Store?
    Zacks

    Henry Schein (HSIC) to Post Q2 Earnings: A Beat in Store?

    Henry Schein (HSIC) is working diligently to grow in the field of digital dentistry, globally.

  • Can Patient Wins Aid GW Pharmaceuticals (GWPH) Q2 Earnings?
    Zacks

    Can Patient Wins Aid GW Pharmaceuticals (GWPH) Q2 Earnings?

    GW Pharmaceuticals (GWPH) is witnessing a solid new patient recruitment for Epidolex and a huge number of physicians are recommending the same in their prescriptions.

  • Can Bruker (BRKR) Q2 Earnings See BioSpin's Growth Revival?
    Zacks

    Can Bruker (BRKR) Q2 Earnings See BioSpin's Growth Revival?

    Bruker (BRKR) expects BioSpin to bode well for better organic growth in Q2.

  • Why Bio-Techne Corporation's (NASDAQ:TECH) High P/E Ratio Isn't Necessarily A Bad Thing
    Simply Wall St.

    Why Bio-Techne Corporation's (NASDAQ:TECH) High P/E Ratio Isn't Necessarily A Bad Thing

    This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios...

  • PR Newswire

    Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay

    MINNEAPOLIS, July 23, 2019 /PRNewswire/ -- Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne for use in its proprietary Simple Plex™ immunoassays on Ella.

  • CBM or TECH: Which Is the Better Value Stock Right Now?
    Zacks

    CBM or TECH: Which Is the Better Value Stock Right Now?

    CBM vs. TECH: Which Stock Is the Better Value Option?

  • PR Newswire

    Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results

    MINNEAPOLIS , July 18, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, August 6, 2019 , at 8:00 a.m. CDT to review fourth ...

  • PR Newswire

    Bio-Techne Releases 32x8 Cartridge For The Ella Platform

    MINNEAPOLIS , July 17, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of a new 8-Plex cartridge format for the ProteinSimple™-branded Ella™ automated immunoassay ...